Literature DB >> 20404135

Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells.

Han M Lee1, Hui Zhang, Vincent Schulz, David P Tuck, Bernard G Forget.   

Abstract

Enforced expression of the homeobox transcription factor HOXB4 has been shown to enhance hematopoietic stem cell self-renewal and expansion ex vivo and in vivo. To investigate the downstream targets of HOXB4 in hematopoietic progenitor cells, HOXB4 was constitutively overexpressed in the primitive hematopoietic progenitor cell line EML. Two genome-wide analytical techniques were used: RNA expression profiling using microarrays and chromatin immunoprecipitation (ChIP)-chip. RNA expression profiling revealed that 465 gene transcripts were differentially expressed in KLS (c-Kit(+), Lin(-), Sca-1(+))-EML cells that overexpressed HOXB4 (KLS-EML-HOXB4) compared with control KLS-EML cells that were transduced with vector alone. In particular, erythroid-specific gene transcripts were observed to be highly down-regulated in KLS-EML-HOXB4 cells. ChIP-chip analysis revealed that the promoter region for 1910 genes, such as CD34, Sox4, and B220, were occupied by HOXB4 in KLS-EML-HOXB4 cells. Side-by-side comparison of the ChIP-chip and RNA expression profiling datasets provided correlative information and identified Gp49a and Laptm4b as candidate "stemness-related" genes. Both genes were highly ranked in both dataset lists and have been previously shown to be preferentially expressed in hematopoietic stem cells and down-regulated in mature hematopoietic cells, thus making them attractive candidates for future functional studies in hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404135      PMCID: PMC2918329          DOI: 10.1182/blood-2009-11-253872

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro.

Authors:  M D Milsom; R Duxbury; D Gagen; R K Humphries; M Schmidt; C von-Kalle; L J Fairbairn
Journal:  Leukemia       Date:  2005-01       Impact factor: 11.528

Review 2.  Clinical strategies for expansion of haematopoietic stem cells.

Authors:  Brian P Sorrentino
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

3.  HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells.

Authors:  Sandra Pilat; Sebastian Carotta; Bernhard Schiedlmeier; Kenji Kamino; Andreas Mairhofer; Elke Will; Ute Modlich; Peter Steinlein; Wolfram Ostertag; Christopher Baum; Hartmut Beug; Hannes Klump
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

4.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

Authors:  G Sauvageau; P M Lansdorp; C J Eaves; D E Hogge; W H Dragowska; D S Reid; C Largman; H J Lawrence; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 5.  Stem cell transplantation (cord blood transplants).

Authors:  Nelson J Chao; Stephen G Emerson; Kenneth I Weinberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

6.  Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability.

Authors:  C L Miller; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression.

Authors:  Grit Kasper; Anke Vogel; Irina Klaman; Jörn Gröne; Iver Petersen; Birgit Weber; Esmeralda Castaños-Vélez; Eike Staub; Detlev Mennerich
Journal:  Cancer Lett       Date:  2004-11-11       Impact factor: 8.679

8.  Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1.

Authors:  J Krosl; S Baban; G Krosl; S Rozenfeld; C Largman; G Sauvageau
Journal:  Oncogene       Date:  1998-07-02       Impact factor: 9.867

9.  Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo.

Authors:  G Sauvageau; U Thorsteinsdottir; C J Eaves; H J Lawrence; C Largman; P M Lansdorp; R K Humphries
Journal:  Genes Dev       Date:  1995-07-15       Impact factor: 11.361

10.  Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells.

Authors:  M Bhatia; D Bonnet; D Wu; B Murdoch; J Wrana; L Gallacher; J E Dick
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

View more
  19 in total

1.  Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.

Authors:  Rong Fan; Sabrina Bonde; Peng Gao; Brendan Sotomayor; Changya Chen; Tyler Mouw; Nicholas Zavazava; Kai Tan
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

2.  Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients.

Authors:  Hua Yang; Guojun Zhai; Xiaoxu Ji; Fuxia Xiong; Jing Su; Michael A McNutt
Journal:  Med Oncol       Date:  2012-12       Impact factor: 3.064

3.  Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.

Authors:  Motohiko Oshima; Mitsuhiro Endoh; Takaho A Endo; Tetsuro Toyoda; Yaeko Nakajima-Takagi; Fumihiro Sugiyama; Haruhiko Koseki; Michael Kyba; Atsushi Iwama; Mitsujiro Osawa
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

4.  HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4.

Authors:  Marilaine Fournier; Charles-Étienne Lebert-Ghali; Janetta J Bijl
Journal:  Stem Cells Dev       Date:  2015-08-12       Impact factor: 3.272

5.  Modulating the malignancy of Hox proteins.

Authors:  Michael Kyba
Journal:  Blood       Date:  2017-01-19       Impact factor: 22.113

Review 6.  Ex vivo expansion of umbilical cord blood: where are we?

Authors:  Omar S Aljitawi
Journal:  Int J Hematol       Date:  2012-03-23       Impact factor: 2.490

7.  A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation.

Authors:  Eszter Doma; Isabella Maria Mayer; Tania Brandstoetter; Barbara Maurer; Reinhard Grausenburger; Ingeborg Menzl; Markus Zojer; Andrea Hoelbl-Kovacic; Leif Carlsson; Gerwin Heller; Karoline Kollmann; Veronika Sexl
Journal:  Blood Adv       Date:  2021-01-12

8.  HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4.

Authors:  Céline Auvray; Andrée Delahaye; Françoise Pflumio; Rima Haddad; Sophie Amsellem; Ayda Miri-Nezhad; Loïc Broix; Azzedine Yacia; Frédérique Bulle; Serge Fichelson; Isabelle Vigon
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

9.  Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.

Authors:  Hui Yu; Geoffrey Neale; Hui Zhang; Han M Lee; Zhijun Ma; Sheng Zhou; Bernard G Forget; Brian P Sorrentino
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

10.  An integrated global regulatory network of hematopoietic precursor cell self-renewal and differentiation.

Authors:  Yanan You; Raquel Cuevas-Diaz Duran; Lihua Jiang; Xiaomin Dong; Shan Zong; Michael Snyder; Jia Qian Wu
Journal:  Integr Biol (Camb)       Date:  2018-07-16       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.